About
Technology
Issues
FAQ
Search
Rankings
Journals
Disciplines
Institutions
Schools/Departments
Field Rankings
Scientometrics
★★(★)
Articles
h
-index
g
-index
Journals
Co-Authors
Publications (by citations)
Publications (by year)
Citation Distribution
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Authors
›
Mohammad Sistanizad
›
journal-rankings
Mohammad Sistanizad
48
(top 10%)
papers
390
(top 50%)
citations
12
(top 20%)
h
-index
18
(top 20%)
g
-index
56
all documents
444
doc citations
293
citing journals
105
times ranked
Filter by:
Articles (Lifetime) (1)
|
Citations (Lifetime) (1)
|
Most Cited Article (Lifetime) (1)
|
Most Cited Article (per year) (8)
|
Low Rankings (Lifetime) (6)
|
Low Rankings (per year) (67)
|
4
th
most cited paper
in
Iranian Journal of Pharmaceutical Research
(2018) [with 53 citations of an article]
8
th
most cited author
in
Iranian Journal of Pharmaceutical Research
(lifetime) [with 194 citations of 20 articles]
10
th
most published author
in
Iranian Journal of Pharmaceutical Research
(lifetime) [with 20 articles having 194 citations]
15
th
most cited paper
in
Current Drug Safety
(2011) [with 23 citations of an article]
18
th
most cited paper
in
Journal of Clinical Pharmacy and Therapeutics
(2013) [with 24 citations of an article]
30
th
most cited paper
in
Iranian Journal of Pharmaceutical Research
(2019) [with 24 citations of an article]
33
rd
most cited paper
in
Iranian Journal of Pharmaceutical Research
(2013) [with 24 citations of an article]
44
th
most cited paper
in
Immunity, Inflammation and Disease
(2022) [with 26 citations of an article]
59
th
most cited paper
in
Journal of Clinical Pharmacology
(2018) [with 31 citations of an article]
65
th
most cited paper
in
Iranian Journal of Pharmaceutical Research
(2015) [with 35 citations of an article]
69
th
most cited paper
in
Iranian Journal of Pharmaceutical Research
(lifetime) [with 194 citations of an article]
site/software ©
exaly
; All materials licenced under
CC by-SA
.